Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in breast cancer patients: Phase 1 dose escalation study von Kogawa, Takahiro, Yonemori, Kan, Masuda, Norikazu, Takahashi, Shunji, Takahashi, Masato, Iwase, Hirotaka, Nakayama, Takahiro, Saeki, Toshiaki, Toyama, Tatsuya, Takano, Toshimi, Onuma, Hiroshi, Ogawa, Hayao, Tanaka, Yoshimi, Igari, Yoshiko, Sugihara, Masahiro, Vigliotti, Michele, Yu, Channing, Olivo, Martin Sebastian, Ueno, Suguru, Iwata, Hiroji

Volltext

Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms von Saini, Kamal S, de Las Heras, Begoña, Plummer, Ruth, Moreno, Victor, Romano, Marco, de Castro, Javier, Aftimos, Philippe, Fredriksson, Judy, Bhattacharyya, Gouri Shankar, Olivo, Martin Sebastian, Schiavon, Gaia, Punie, Kevin, Garcia-Foncillas, Jesus, Rogata, Ernesto, Pfeiffer, Richie, Orbegoso, Cecilia, Morrison, Kenneth, Curigliano, Giuseppe, Chin, Lynda, Saini, Monika Lamba, Rekdal, Øystein, Anderson, Steven, Cortes, Javier, Leone, Manuela, Dancey, Janet, Twelves, Chris, Awada, Ahmad

Volltext

GNC-038, a tetra-specific antibody, in patients with R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia: A phase 1 study design and rationale von Wang, Jianxiang, Qi, Junyuan, Li, Wenyu, Zhai, Zhimin, Li, Ping, Zou, Wen, Ding, Muran, Yang, Xue, Wang, Rong, Guo, Wanjing, Xiao, Sa, Khalili, Jahan S., Zhu, Hai, Olivo, Martin Sebastian, Zhu, Yi

Volltext

BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 st... von Zhang, Li, Ma, Yuxiang, Zhao, Yuanyuan, Fang, Wenfeng, Zhao, Hongyun, Huang, Yan, Yang, Yunpeng, Chen, Likun, Hou, Xue, Zou, Wen, Ding, Muran, Yu, Jing, Zhang, Suoyu, Wang, Junxian, Xiao, Sa, Wang, Hongwei, Zhu, Hai, Olivo, Martin Sebastian, Zhu, Yi

Volltext

Results from two phase II studies of SI-B001, an EGFR×HER3 bispecific antibody, with/without chemotherapy in patients (pts) with recurrent and metastatic head and neck squamous cel... von Xue, Liqiong, Yang, Kunyu, Fang, Meiyu, Ma, Xuelei, Zou, Wen, Ding, Muran, Wang, Zhaoxiang, Peng, Yujia, Xiao, Sa, Wang, Hongwei, Zhu, Hai, Olivo, Martin Sebastian, Zhu, Yi, Guo, Ye

Volltext

SI-B003 (PD-1/CTLA-4) in patients with advanced solid tumors: A phase I study von Wang, Yakun, Li, Yongsheng, Liu, Jiyan, Luo, Su-xia, Li, Qi, Zou, Wen, Wang, Zhaoxiang, Peng, Yujia, Xiao, Sa, Wang, Hongwei, Zhu, Hai, Olivo, Martin Sebastian, Zhu, Yi, Shen, Lin

Volltext

SI-B001 plus chemotherapy in patients with locally advanced or metastatic EGFR/ALK wild-type non-small cell lung cancer: A phase II, multicenter, open-label study von Zhao, Yuanyuan, Zhang, Li, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Zou, Wen, Wang, Zhaoxiang, Ding, Muran, Peng, Yujia, Xiao, Sa, Wang, Hongwei, Zhu, Hai, Olivo, Martin Sebastian, Zhu, Yi

Volltext

Assessment of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) cohort by agent in the phase 3 ASCENT study of patients (pts) with metastatic triple-negative... von O'Shaughnessy, Joyce, Punie, Kevin, Oliveira, Mafalda, Lynce, Filipa, Tolaney, Sara M., Dalenc, Florence, Sharma, Priyanka, Tsai, Michaela L., Bardia, Aditya, Cortes, Javier, Danso, Michael A., Henry, Stephanie, Perez, Alejandra T., Hurvitz, Sara A., Kalinsky, Kevin, Hong, Quan, Olivo, Martin Sebastian, Itri, Loretta, Rugo, Hope S.

Volltext

Assessment of sacituzumab govitecan (SG) in patients with prior neoadjuvant/adjuvant chemotherapy in the phase 3 ASCENT study in metastatic triple-negative breast cancer (mTNBC) von Carey, Lisa A., Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Dieras, Veronique, Dalenc, Florence, Diamond, Jennifer Robinson, Fontaine, Christel, Wang, Grace, Rugo, Hope S., Hurvitz, Sara A., Kalinsky, Kevin, O'Shaughnessy, Joyce, Loibl, Sibylle, Gianni, Luca, Piccart-Gebhart, Martine J., Hong, Quan, Olivo, Martin Sebastian, Itri, Loretta, Cortes, Javier

Volltext

Outcomes in patients (pts) aged ≥65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC) von Kalinsky, Kevin, Oliveira, Mafalda, Traina, Tiffany A., Tolaney, Sara M., Loirat, Delphine, Punie, Kevin, Hurvitz, Sara A., Lynce, Filipa, Hamilton, Erika P., Nanda, Rita, Hart, Lowell L., Richards, Paul D., Malik, Zulfiqar A., Rugo, Hope S., Dieras, Veronique, Bardia, Aditya, Hong, Quan, Olivo, Martin Sebastian, Itri, Loretta, Loibl, Sibylle

Volltext

Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms von Saini, Kamal S, de las Heras, Begona, Plummer, Ruth, Moreno, Victor, Romano, Marco, de Castro, Javier, Aftimos, Philippe, Fredriksson, Judy, Bhattacharyya, Gouri Shankar, Olivo, Martin Sebastian, Schiavon, Gaia, Punie, Kevin, Garcia-Foncillas, Jesus, Rogata, Ernesto, Pfeiffer, Richie, Orbegoso, Cecilia, Morrison, Kenneth, Curigliano, Giuseppe, Chin, Lynda, Saini, Monika Lamba, Rekdal, Oystein, Anderson, Steven, Cortes, Javier, Leone, Manuela, Dancey, Janet, Twelves, Chris, Awada, Ahmad

Volltext

NCIC IND.190: A phase I trial of MK-0646 in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (ES SCLC) von Ellis, Peter Michael, Shepherd, Frances A., Laurie, Scott Andrew, Goss, Glenwood D., Olivo, Martin Sebastian, Powers, Jean, Walsh, Wendy, Seymour, Lesley, Bradbury, Penelope Ann

Volltext

Experiencia preliminar con cidofovir en una consulta dermatológica de pacientes con infección por VIH von ZARCO OLIVO, C, LLAMAS MARTIN, R, POSTIGO LLORENTE, C, MUNOZ GARCIA, M. J, VANACLOCHA SEBASTIAN, F

Volltext

Nueva Dramaturgia Andaluza. Lecturas dramatizadas Cádiz von Ruth Lladó, Ángel Mendoza

Volltext bestellen